271 related articles for article (PubMed ID: 34196428)
1. The PDZ protein SCRIB regulates sodium/iodide symporter (NIS) expression at the basolateral plasma membrane.
Martín M; Salleron L; Peyret V; Geysels RC; Darrouzet E; Lindenthal S; Bernal Barquero CE; Masini-Repiso AM; Pourcher T; Nicola JP
FASEB J; 2021 Aug; 35(8):e21681. PubMed ID: 34196428
[TBL] [Abstract][Full Text] [Related]
2. An Intramolecular Ionic Interaction Linking Defective Sodium/Iodide Symporter Transport to the Plasma Membrane and Dyshormonogenic Congenital Hypothyroidism.
Bernal Barquero CE; Martín M; Geysels RC; Peyret V; Papendieck P; Masini-Repiso AM; Chiesa AE; Nicola JP
Thyroid; 2022 Jan; 32(1):19-27. PubMed ID: 34726525
[No Abstract] [Full Text] [Related]
3. A Carboxy-Terminal Monoleucine-Based Motif Participates in the Basolateral Targeting of the Na+/I- Symporter.
Martín M; Modenutti CP; Peyret V; Geysels RC; Darrouzet E; Pourcher T; Masini-Repiso AM; Martí MA; Carrasco N; Nicola JP
Endocrinology; 2019 Jan; 160(1):156-168. PubMed ID: 30496374
[TBL] [Abstract][Full Text] [Related]
4. A Novel SLC5A5 Variant Reveals the Crucial Role of Kinesin Light Chain 2 in Thyroid Hormonogenesis.
Martín M; Modenutti CP; Gil Rosas ML; Peyret V; Geysels RC; Bernal Barquero CE; Sobrero G; Muñoz L; Signorino M; Testa G; Miras MB; Masini-Repiso AM; Calcaterra NB; Coux G; Carrasco N; Martí MA; Nicola JP
J Clin Endocrinol Metab; 2021 Jun; 106(7):1867-1881. PubMed ID: 33912899
[TBL] [Abstract][Full Text] [Related]
5. Novel Sodium/Iodide Symporter Compound Heterozygous Pathogenic Variants Causing Dyshormonogenic Congenital Hypothyroidism.
Martín M; Bernal Barquero CE; Geysels RC; Papendieck P; Peyret V; Masini-Repiso AM; Chiesa AE; Nicola JP
Thyroid; 2019 Jul; 29(7):1023-1026. PubMed ID: 31115276
[TBL] [Abstract][Full Text] [Related]
6. The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.
Paroder V; Nicola JP; Ginter CS; Carrasco N
J Cell Sci; 2013 Aug; 126(Pt 15):3305-13. PubMed ID: 23690546
[TBL] [Abstract][Full Text] [Related]
7. A systematic evaluation of sorting motifs in the sodium-iodide symporter (NIS).
Darrouzet E; Graslin F; Marcellin D; Tcheremisinova I; Marchetti C; Salleron L; Pognonec P; Pourcher T
Biochem J; 2016 Apr; 473(7):919-28. PubMed ID: 26831514
[TBL] [Abstract][Full Text] [Related]
8. Brief Report: A Novel Sodium/Iodide Symporter Mutation, S356F, Causing Congenital Hypothyroidism.
Durgia H; Nicholas AK; Schoenmakers E; Dickens JA; Halanaik D; Sahoo J; Kamalanathan S; Schoenmakers N
Thyroid; 2022 Feb; 32(2):215-218. PubMed ID: 34806438
[TBL] [Abstract][Full Text] [Related]
9. Impact of the Mutational Landscape of the Sodium/Iodide Symporter in Congenital Hypothyroidism.
Martín M; Nicola JP
Thyroid; 2021 Dec; 31(12):1776-1785. PubMed ID: 34514854
[No Abstract] [Full Text] [Related]
10. The Iodide Transport Defect-Causing Y348D Mutation in the Na
Reyna-Neyra A; Jung L; Chakrabarti M; Suárez MX; Amzel LM; Carrasco N
Thyroid; 2021 Aug; 31(8):1272-1281. PubMed ID: 33779310
[No Abstract] [Full Text] [Related]
11. Iodide handling disorders (NIS, TPO, TG, IYD).
Targovnik HM; Citterio CE; Rivolta CM
Best Pract Res Clin Endocrinol Metab; 2017 Mar; 31(2):195-212. PubMed ID: 28648508
[TBL] [Abstract][Full Text] [Related]
12. Congenital hypothyroidism due to a new deletion in the sodium/iodide symporter protein.
Tonacchera M; Agretti P; de Marco G; Elisei R; Perri A; Ambrogini E; De Servi M; Ceccarelli C; Viacava P; Refetoff S; Panunzi C; Bitti ML; Vitti P; Chiovato L; Pinchera A
Clin Endocrinol (Oxf); 2003 Oct; 59(4):500-6. PubMed ID: 14510914
[TBL] [Abstract][Full Text] [Related]
13. The sodium/iodide symporter: state of the art of its molecular characterization.
Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of the purified human sodium/iodide symporter reveals that the protein is mainly present in a dimeric form and permits the detailed study of a native C-terminal fragment.
Huc-Brandt S; Marcellin D; Graslin F; Averseng O; Bellanger L; Hivin P; Quemeneur E; Basquin C; Navarro V; Pourcher T; Darrouzet E
Biochim Biophys Acta; 2011 Jan; 1808(1):65-77. PubMed ID: 20797386
[TBL] [Abstract][Full Text] [Related]
15. The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.
De La Vieja A; Ginter CS; Carrasco N
J Cell Sci; 2004 Feb; 117(Pt 5):677-87. PubMed ID: 14734652
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.
De La Vieja A; Dohan O; Levy O; Carrasco N
Physiol Rev; 2000 Jul; 80(3):1083-105. PubMed ID: 10893432
[TBL] [Abstract][Full Text] [Related]
17. Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid.
Bizhanova A; Kopp P
Endocrinology; 2009 Mar; 150(3):1084-90. PubMed ID: 19196800
[TBL] [Abstract][Full Text] [Related]
18. Implications of Na
Martín M; Geysels RC; Peyret V; Bernal Barquero CE; Masini-Repiso AM; Nicola JP
J Endocr Soc; 2019 Jan; 3(1):222-234. PubMed ID: 30620007
[TBL] [Abstract][Full Text] [Related]
19. Scribble associates with two polarity proteins, Lgl2 and Vangl2, via distinct molecular domains.
Kallay LM; McNickle A; Brennwald PJ; Hubbard AL; Braiterman LT
J Cell Biochem; 2006 Oct; 99(2):647-64. PubMed ID: 16791850
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the sodium/iodide symporter (NIS) gene as a cause for iodide transport defects and congenital hypothyroidism.
Pohlenz J; Refetoff S
Biochimie; 1999 May; 81(5):469-76. PubMed ID: 10403177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
